PMID: 25735377Mar 5, 2015Paper

Prognostic factors, treatment and outcome in a Turkish population with endometrial stromal sarcoma

Asian Pacific Journal of Cancer Prevention : APJCP
Ayla DonertasYusuf Yildirim

Abstract

To analyze treatment modalities and prognostic factors in patients with Stage I-II endometrial stromal sarcoma (ESS). Twenty four patients (nineteen with low-grade ESS [LGESS] and five with high-grade ESS [HGESS]) were assessed retrospectively in terms of general characteristics, prognostic factors, treatment methods and survival. Twenty patients were at Stage I and three were at Stage II. The stage of one patient could not be determined. With respect to age and comorbidity, no statistically significant difference was found among disease-free survival (DFS) (p=0.990; p=0.995). However, DFS was significantly shorter in Stage II than Stage I patients (p=0.002). It was also significantly shorter in HGESS patients than in LGESS patients (p=0.000). There was no statistically significant differences among the overall survival (OVS) times of patients with respect to age at diagnosis and comorbid disease (p=0.905; p=0.979) but OVS was significantly shorter in patients with HGESS (p=0.00) and Stage II disease (p=0.001). No statistically significant difference was found with respect to OVS between patients who received radiotherapy (RT) and those who did not receive RT (p=0.055). It was not statistically possible to include other treatme...Continue Reading

References

Jan 1, 1990·Gynecologic Oncology·J L MansiC Fisher
Jan 1, 1990·Gynecologic Oncology·A BerchuckJ L Lewis
May 1, 1990·The American Journal of Surgical Pathology·K L ChangM R Hendrickson
May 1, 1990·European Journal of Obstetrics, Gynecology, and Reproductive Biology·B LarsonF Pettersson
Jul 1, 1990·Cancer·G EchtZ Petrovich
Nov 1, 1996·Gynecologic Oncology·A GadducciA Fanucchi
Sep 5, 2001·Gynecologic Oncology·F C MalufC Aghajanian
Jun 25, 2003·Gynecologic Oncology·Micheline C ChuPeter E Schwartz
Jul 16, 2003·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Ali HaberalM Faruk Köse
Mar 30, 2004·Gynecologic Oncology·Sandra E BrooksClaudia R Baquet
Jan 22, 2005·Gynecologic Oncology·J RiopelB Têtu
Dec 2, 2005·Obstetrics and Gynecology·Andrew J LiBeth Y Karlan
Feb 27, 2007·Gynecologic Oncology·Charles A LeathMichael A Gold
Mar 16, 2007·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·M IhnenJ Schwarz
Mar 17, 2007·Pathology·Farid MoinfarFattaneh A Tavassoli
Jul 20, 2007·American Journal of Clinical Pathology·Maria Luisa Policarpio-NicolasEdward B Stelow
Aug 21, 2007·Critical Reviews in Oncology/hematology·Angiolo GadducciAndrea Riccardo Genazzani
Sep 25, 2008·British Journal of Cancer·J K ChanD S Kapp
Jan 13, 2009·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Jaime Prat
Oct 14, 2009·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Brandon BarneyDavid K Gaffney
Mar 23, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G G MaloufP Pautier
Jun 29, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·P G CasaliUNKNOWN ESMO/CONTICANET/EUROBONET Consensus Panel of experts
Jul 19, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Angiolo Gadducci
Aug 9, 2011·Best Practice & Research. Clinical Obstetrics & Gynaecology·Wei-Cheng Xue, Annie N Y Cheung
Mar 27, 2012·Hematology/oncology and Stem Cell Therapy·R TanzH Errihani
Aug 21, 2012·Asian Pacific Journal of Cancer Prevention : APJCP·Ayşe DurnaliUNKNOWN Anatolian Society of Medical Oncology (ASMO)
Aug 8, 2013·Obstetrics and Gynecology·J Alejandro Rauh-Hain, Marcela G del Carmen

❮ Previous
Next ❯

Citations

Sep 4, 2016·Taiwanese Journal of Obstetrics & Gynecology·Huann-Cheng HorngUNKNOWN Taiwan Association of Gynecology Systematic Review Group
Aug 26, 2020·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Jie WuQibin Song

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Obstetrics, Gynecology, and Reproductive Biology
Ali HaberalM Faruk Köse
The Journal of Reproductive Medicine
J Alejandro Rauh-HainMarcela G del Carmen
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Jeong-Yeol ParkJoo-Hyun Nam
© 2022 Meta ULC. All rights reserved